Anticancer efficacy of Apo2L/TRAIL is re
✍
Irene Zinonos; Agatha Labrinidis; Michelle Lee; Vasilios Liapis; Shelley Hay; Vl
📂
Article
📅
2011
🏛
American Society for Bone and Mineral Research
🌐
English
⚖ 590 KB
## Abstract Osteoprotegerin (OPG) is a secreted member of the tumor necrosis factor (TNF) receptor superfamily that binds to the ligand for receptor activator of nuclear factor κB (RANKL) and inhibits bone resorption. OPG can also bind and inhibit the activity of the TNF‐related apoptosis‐inducing